- Home
- EVH vs BOE Comparison
EVH vs BOE Comparison
Compare EVH & BOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVH | BOE |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 667.0M | 649.4M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | EVH | BOE |
|---|---|---|
| Price | $4.22 | $11.80 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $5.75 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 160.6K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.30% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $907,957,000.00 | N/A |
| Revenue This Year | $40.46 | N/A |
| Revenue Next Year | $25.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.10 | $10.59 |
| 52 Week High | $8.30 | $12.58 |
Technical Indicators
Market Signals| Indicator | EVH | BOE |
|---|---|---|
| Relative Strength Index (RSI) | 59.81 | 42.78 |
| Support Level | $3.61 | $11.70 |
| Resistance Level | $4.54 | $12.03 |
| Average True Range (ATR) | 0.20 | 0.17 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 99.44 | 40.28 |
Price Performance
Historical ComparisonAbout EVH Evolent Health Inc
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
About BOE Blackrock Enhanced Global Dividend Trust of Beneficial Interest
Blackrock Enhanced Global Dividend Trust is a closed-end management investment company. Its investment objective is to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. The Trust seeks to achieve its investment objectives by investing in equity securities issued by companies located in countries throughout the world.